$1.72 Billion is the total value of Alphabet Inc.'s 61 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 4.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Prime Medicine, Inc. | $246,829,503 | – | 13,284,688 | +100.0% | 14.34% | – | |
| VERV | Sell | Verve Therapeutics Inc. | $204,124,814 | -45.8% | 10,549,086 | -3.9% | 11.86% | -38.4% |
| PATH | UiPath Inccl a | $178,812,847 | +0.8% | 14,068,674 | 0.0% | 10.38% | +14.6% | |
| DXCM | Sell | Dexcom Inc | $141,550,000 | -12.1% | 1,250,000 | -37.5% | 8.22% | -0.0% |
| Planet Labs PBC | $138,950,488 | -19.9% | 31,942,641 | 0.0% | 8.07% | -8.9% | ||
| Buy | EQRX Inc | $117,281,671 | -50.2% | 47,675,476 | +0.3% | 6.81% | -43.3% | |
| SNOW | Snowflake Inccl a | $76,880,598 | -15.5% | 535,604 | 0.0% | 4.46% | -3.9% | |
| CRWD | New | Crowdstrike Hldgs Inccl a | $65,498,066 | – | 622,073 | +100.0% | 3.80% | – |
| Freshworks Inc | $59,363,603 | +13.4% | 4,035,595 | 0.0% | 3.45% | +29.0% | ||
| OSCR | Oscar Health Inc. | $59,145,444 | -50.7% | 24,042,864 | 0.0% | 3.44% | -43.9% | |
| Buy | Gitlab Inc. | $58,823,307 | +93.5% | 1,294,527 | +118.2% | 3.42% | +120.1% | |
| LYFT | Sell | Lyft Inc | $57,938,344 | -28.3% | 5,257,563 | -14.3% | 3.36% | -18.5% |
| Duolingo Inc. | $50,107,102 | -25.3% | 704,444 | 0.0% | 2.91% | -15.1% | ||
| Robinhood Mkts Inc | $40,118,275 | -19.4% | 4,928,535 | 0.0% | 2.33% | -8.3% | ||
| Benson Hill Inc. | $39,658,291 | -5.7% | 15,352,271 | 0.0% | 2.30% | +7.2% | ||
| RLAY | Relay Therapeutics Inc. | $23,437,170 | -33.2% | 1,568,753 | 0.0% | 1.36% | -24.1% | |
| LYEL | Lyell Immunopharma Inc. | $20,351,984 | -52.7% | 5,865,125 | 0.0% | 1.18% | -46.2% | |
| DM | Desktop Metal Inc. | $15,026,273 | -47.5% | 11,048,730 | 0.0% | 0.87% | -40.2% | |
| ME | 23andMe Holding Co. | $14,551,456 | -24.5% | 6,736,785 | 0.0% | 0.84% | -14.1% | |
| BEAM | Beam Therapeutics Inc. | $12,577,932 | -17.9% | 321,604 | 0.0% | 0.73% | -6.5% | |
| GLUE | Monte Rosa Therapeutics Inc. | $11,141,154 | -6.9% | 1,464,015 | 0.0% | 0.65% | +5.9% | |
| SANA | Sana Biotechnology Inc. | $11,109,375 | -34.2% | 2,812,500 | 0.0% | 0.64% | -25.2% | |
| ILMN | Illumina Inc. | $10,811,634 | +6.0% | 53,470 | 0.0% | 0.63% | +20.5% | |
| RAPT | RAPT Therapeutics Inc. | $10,697,346 | -17.7% | 540,270 | 0.0% | 0.62% | -6.5% | |
| Invivyd Inc. | $8,521,178 | -52.1% | 5,680,785 | 0.0% | 0.50% | -45.5% | ||
| VERA | Vera Therapeutics Inc.cl a | $5,835,573 | -9.2% | 301,580 | 0.0% | 0.34% | +3.4% | |
| NEWR | New Relic Inc. | $5,144,401 | -1.6% | 91,132 | 0.0% | 0.30% | +12.0% | |
| VACC | Vaccitech PLCads | $3,557,063 | -26.6% | 1,513,644 | 0.0% | 0.21% | -16.2% | |
| DBTX | Decibel Therapeutics Inc. | $3,354,329 | -40.7% | 1,636,258 | 0.0% | 0.20% | -32.5% | |
| FHTX | Foghorn Therapeutics Inc. | $3,195,748 | -25.6% | 500,901 | 0.0% | 0.19% | -15.1% | |
| Sell | Rani Therapeutics Hldgs Inc. | $3,009,755 | -56.0% | 510,128 | -28.6% | 0.18% | -50.0% | |
| KRON | Kronos Bio Inc. | $2,329,936 | -51.6% | 1,438,232 | 0.0% | 0.14% | -45.1% | |
| Amplitude Inc | $2,288,520 | -21.9% | 189,447 | 0.0% | 0.13% | -11.3% | ||
| FULC | Fulcrum Therapeutics Inc. | $1,859,690 | -10.0% | 255,452 | 0.0% | 0.11% | +2.9% | |
| Tenaya Therapeutics Inc. | $1,840,567 | -30.7% | 915,705 | 0.0% | 0.11% | -21.3% | ||
| EVLO | Evelo Biosciences Inc. | $1,707,397 | -23.0% | 1,060,495 | 0.0% | 0.10% | -12.4% | |
| Tscan Therapeutics Inc. | $1,647,932 | -49.8% | 1,077,080 | 0.0% | 0.10% | -42.9% | ||
| ALEC | Alector Inc. | $1,623,243 | -2.4% | 175,866 | 0.0% | 0.09% | +10.6% | |
| SPRO | Spero Therapeutics Inc. | $1,539,664 | -13.5% | 889,979 | 0.0% | 0.09% | -2.2% | |
| TSHA | Taysha Gene Therapies Inc. | $1,448,393 | +17.1% | 640,882 | 0.0% | 0.08% | +33.3% | |
| MGTA | Magenta Therapeutics Inc. | $1,335,655 | -71.6% | 3,339,138 | 0.0% | 0.08% | -67.5% | |
| Science 37 Holdings Inc. | $1,347,049 | -73.9% | 3,207,260 | 0.0% | 0.08% | -70.5% | ||
| AUTL | Autolus Therapeutics PLCspon adr | $1,326,698 | -11.2% | 698,262 | 0.0% | 0.08% | +1.3% | |
| EXAS | Exact Sciences Corp | $1,148,880 | +52.4% | 23,205 | 0.0% | 0.07% | +71.8% | |
| Sell | Velo3d Inc | $1,024,596 | -94.7% | 572,400 | -88.3% | 0.06% | -93.9% | |
| Hyperfine Inc. | $754,925 | +3.7% | 898,720 | 0.0% | 0.04% | +18.9% | ||
| OPRT | Oportun Finl Corp | $522,282 | +26.2% | 94,788 | 0.0% | 0.03% | +42.9% | |
| NVTA | Invitae Corp | $401,695 | -24.1% | 215,965 | 0.0% | 0.02% | -14.8% | |
| CRTX | Quince Therapeutics Inc | $121,038 | -52.0% | 189,122 | 0.0% | 0.01% | -46.2% | |
| RGEN | Repligen Corp | $64,846 | -9.9% | 383 | 0.0% | 0.00% | 0.0% | |
| Cue Health Inc | $55,890 | -31.0% | 27,000 | 0.0% | 0.00% | -25.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
| 4 | 2024-04-17 |
| 4 | 2024-04-15 |
| 144 | 2024-04-12 |
| 4 | 2024-04-04 |
| 144 | 2024-04-03 |
| 144 | 2024-04-03 |
| 4 | 2024-04-02 |
| 4 | 2024-04-02 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.